Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 4 minute read Pharma Industry News ESTEVE acquires Caprelsa from Sanofi to boost rare cancer drug portfolio and global specialty focus ESTEVE is acquiring Caprelsa® from Sanofi to expand its rare cancer drug portfolio. The deal boosts ESTEVE's focus on highly specialized treatments. byPallavi MadhirajuJuly 2, 2025